Nektar Therapeutics
NKTR
#6498
Rank
HK$5.93 B
Marketcap
HK$291.65
Share price
5.96%
Change (1 day)
200.52%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$62.22

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$62.27. In 2024 the company made an earnings per share (EPS) of -HK$69.22 an increase over its 2023 EPS that were of -HK$171.10.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$62.22-10.11%
2024-HK$69.22-59.54%
2023-HK$171.10-25.89%
2022-HK$230.87-31.12%
2021-HK$335.1614.86%
2020-HK$291.80-1.19%
2019-HK$295.32-163.96%
2018HK$461.73-725.4%
2017-HK$73.83-42.73%
2016-HK$128.9183.33%
2015-HK$70.3139.53%
2014-HK$50.39-69.29%
2013-HK$164.07-6.67%
2012-HK$175.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.44-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$5.16-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.71-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.17-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland